Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
Ravichandran S, Mahmood S, Wisniowski B, Sachchithanantham S, Popat R, Lachmann H, Rabin N, Ramasamy K, Hawkins S, Kyriakou C, Gillmore J, Yong K, Hawkins P, Jackson G, Pratt G, D Wechalekar A. Ravichandran S, et al. Among authors: wisniowski b. Br J Haematol. 2022 Jul;198(2):328-332. doi: 10.1111/bjh.18216. Epub 2022 May 4. Br J Haematol. 2022. PMID: 35509237
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
Ravichandran S, Law S, Mahmood S, Wisniowski B, Foard D, Fontana M, Martinez-Naharro A, Whelan C, Gillmore JD, Lachmann HJ, Hawkins PN, Wechalekar AD. Ravichandran S, et al. Among authors: wisniowski b. Leukemia. 2022 Apr;36(4):1180-1184. doi: 10.1038/s41375-021-01497-7. Epub 2022 Jan 6. Leukemia. 2022. PMID: 34987193 Free PMC article. No abstract available.
Long-term outcomes in light chain deposition disease-analysis of a UK cohort.
Ravichandran S, Law S, Mahmood S, Wisniowski B, Foard D, Fontana M, Martinez-Naharro A, Whelan C, Hawkins PN, Gillmore JD, Lachmann HJ, Wechalekar AD. Ravichandran S, et al. Among authors: wisniowski b. Am J Hematol. 2022 Dec;97(12):E444-E446. doi: 10.1002/ajh.26725. Epub 2022 Sep 24. Am J Hematol. 2022. PMID: 36088630 Free article. No abstract available.
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
Asher S, Shah R, Ings S, Horder J, Newrick F, Nesr G, Kesse Adu R, Streetly M, Trompeter S, Lee L, Wisniowski B, Mahmood S, Xu K, Papanikalaou X, McMillan A, Popat R, Yong K, Sive J, Kyriakou C, Rabin N. Asher S, et al. Among authors: wisniowski b. Br J Haematol. 2023 Sep;202(6):1224-1227. doi: 10.1111/bjh.18990. Epub 2023 Jul 24. Br J Haematol. 2023. PMID: 37488061 No abstract available.
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.
Bomsztyk J, Ravichandran S, Giles HV, Wright N, Berlanga O, Khwaja J, Mahmood S, Wisniowski B, Cohen O, Foard D, Gilbertson J, Rauf MU, Starr N, Martinez-Naharro A, Venneri L, Whelan C, Fontana M, Hawkins PN, Gillmore JD, Lachmann H, Harding S, Pratt G, Wechalekar AD. Bomsztyk J, et al. Among authors: wisniowski b. Blood. 2024 Mar 28;143(13):1259-1268. doi: 10.1182/blood.2023022399. Blood. 2024. PMID: 38194690
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.
Nesr G, Shah R, Kyriakou C, Sive J, Popat R, Yong K, Wisniowski B, Xu K, Wechalekar A, Lee L, Ings S, Papanikolaou X, Mahmood S, Mcmillan A, Horder J, Newrick F, Marfil J, Ainley L, Asher S, Cheesman S, Rabin N. Nesr G, et al. Among authors: wisniowski b. Leuk Lymphoma. 2023 Jul-Aug;64(8):1465-1471. doi: 10.1080/10428194.2023.2216817. Epub 2023 Jun 1. Leuk Lymphoma. 2023. PMID: 37259553
36 results